Dual role of SOD2 expression has been suggested in ovarian cancer as tumor suppressor and protumoregenic factor (53, 63–65); therefore, antioxidant capacity of HGSOC need to be critically evaluated in future studies. The gene discussed is SOD2; the disease is ovarian carcinoma.